Retraction Note: PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats (International Journal of Obesity, (2014), 38, 3, (456-465), 10.1038/ijo.2013.116);PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats

International Journal of Obesity

Volumn 38, Issue 3, 2014, Pages 456-465

  Sodhi, K ^a   Puri, N ^b   Kim, D H ^a   Hinds, T D ^b   Stechschulte, L A ^b   Favero, G ^c   Rodella, L ^c   Shapiro, J I ^a   Jude, D ^a   Abraham, N G ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

adipogenesis; adiponectin; angiotensin II; HO 1; PPAR

Indexed keywords

ADIPONECTIN; ANGIOTENSIN II; COMPLEMENTARY DNA; CYTOKINE; GLUCOSE; HEME OXYGENASE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; RENIN; STANNSOPORFIN; TRIACYLGLYCEROL; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CATABOLISM; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; ENERGY EXPENDITURE; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOLYSIS; LIVER WEIGHT; METABOLIC PARAMETERS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROADIPOCYTE; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BLOOD; ENZYME ACTIVATION; KIDNEY; METABOLISM; PROMOTER REGION; RENOVASCULAR HYPERTENSION; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ADIPOCYTES; ANGIOTENSIN II; ANIMALS; ENZYME ACTIVATION; HEME OXYGENASE-1; HYPERTENSION, RENOVASCULAR; KIDNEY; PPAR DELTA; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RENIN;

EID: 84896318963     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/s41366-024-01588-2     Document Type: Erratum

References (32)

1. Ueno T, Fujimori K. Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2alpha receptor mediated activation of MEK/ERK-CREB cascade. FEBS J 2011; 278: 2901-2912
2. Matsushita K, Wu Y, Okamoto Y, Pratt RE, Dzau VJ. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 2006; 48: 1095-1102
3. Sodhi K, Puri N, Inoue K, Falck JR, Schwartzman ML, Abraham NG. EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Prostaglandins Other Lipid Mediat 2012; 98: 133-142
4. Kim DH, Burgess AP, Li M, Tsenovoy PL, Addabbo F, McClung JA et al. Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines, tumor necrosis factor-Alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. J Pharmacol Exp Ther 2008; 325: 833-840
5. Puri N, Sodhi K, Haarstad M, Kim DH, Bohinc S, Foglio E et al. Heme induced oxidative stress attenuates sirtuin1 and enhances adipogenesis in mesenchymal stem cells and mouse pre-Adipocytes. J Cell Biochem 2012; 113: 1926-1935
6. Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 2010; 6: 71-82
7. Hung WW, Hsieh TJ, Lin T, Chou PC, Hsiao PJ, Lin KD et al. Blockade of the renin-Angiotensin system ameliorates apelin production in 3T3-L1 adipocytes. Cardiovasc Drugs Ther 2011; 25: 3-12
8. Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-Angiotensin system. Curr Hypertens Rep 2008; 10: 93-98
9. Botros FT, Schwartzman ML, Stier Jr CT, Goodman AI, Abraham NG. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 2005; 68: 2745-2755
10. Mogi M, Iwai M, Horiuchi M. Emerging concept of adipogenesis regulation by the renin-Angiotensin system. Hypertension 2006; 48: 1020-1022
11. Ehrenborg E, Krook A. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-Activated receptor delta. Pharmacol Rev 2009; 61: 373-393
12. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H et al. Peroxisome- proliferatoractivated receptor delta activates fat metabolism to prevent obesity. Cell 2003; 113: 159-170
13. Kim HJ, Ham SA, Paek KS, Hwang JS, Jung SY, Kim MY et al. Transcriptional up-regulation of antioxidant genes by PPARdelta inhibits angiotensin II-induced premature senescence in vascular smooth muscle cells. Biochem Biophys Res Commun 2011; 406: 564-569
14. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60: 79-127
15. Abraham NG, Cao J, Sacerdoti D, Li X, Drummond G. Heme oxygenase: The key to renal function regulation. Am J Physiol Renal Physiol 2009; 297: F1137-F1152
16. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005; 39: 1-25
17. Cao J, Sodhi K, Inoue K, Quilley J, Rezzani R, Rodella L et al. Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum Gene Ther 2011; 22: 271-282
18. Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J Lipid Res 2009; 50: 1293-1304
19. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008; 57: 1526-1535
20. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S et al. L-4F treatment reduces adiposity, increases adiponectin levels and improves insulin sensitivity in obese mice. J Lipid Res 2008; 49: 1658-1669
21. Sodhi K, Inoue K, Gotlinger K, Canestraro M, Vanella L, Kim DH et al. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J Pharmacol Exp Ther 2009; 331: 906-916
22. Vanella L, Li M, Kim D, Malfa G, Bellner L, Kawakami T et al. ApoA1: Mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b. Cell Cycle 2012; 11: 706-714
23. Ferder L, Inserra F, Martinez-Maldonado M. Inflammation and the metabolic syndrome: Role of angiotensin II and oxidative stress. Curr Hypertens Rep 2006; 8: 191-198
24. Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Angiotensin II and inflammation: The effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens 2007; 21: 20-27
25. Cao J, Peterson SJ, Sodhi K, Vanella L, Barbagallo I, Rodella LF et al. Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet. Hypertension 2012; 60: 467-475
26. Immenschuh S, Hinke V, Katz N, Kietzmann T. Transcriptional induction of heme oxygenase-1 gene expression by okadaic acid in primary rat hepatocyte cultures. Mol Pharmacol 2000; 57: 610-618
27. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002; 277: 30998-31004
28. Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA. Impact of obesity on cardiovascular disease. Med Clin North Am 2011; 95: 919-937
29. Schnegg CI, Robbins ME. Neuroprotective mechanisms of PPARdelta: Modulation of oxidative stress and inflammatory processes. PPAR Res 2011; 2011: 373560
30. Wang YX. PPARs: Diverse regulators in energy metabolism and metabolic diseases. Cell Res 2010; 20: 124-137
31. Olson EJ, Pearce GL, Jones NP, Sprecher DL. Lipid effects of peroxisome proliferator-Activated receptor-delta agonist GW501516 in subjects with low high-density lipoprotein cholesterol: Characteristics of metabolic syndrome. Arterioscler Thromb Vasc Biol 2012; 32: 2289-2294
32. Hu CM, Chen YH, Chiang MT, Chau LY. Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 2004; 110: 309-316